Leslie Dakin
Impact in
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
-
- interferon and immune responses
Papers in
-
- Renal Diseases and Glomerulopathies 2
-
- Epigenetics and DNA Methylation 1
- Cancer-related gene regulation 1
- RNA modifications and cancer 1
- Co-authors
- A H Fortier (2 shared papers)Brandon Zimmerman (2 shared papers)George Manos (1 shared paper)David J. Friedman (1 shared paper)Kate Bramham (1 shared paper)Bertrand Knebelmann (1 shared paper)Martin R. Pollak (1 shared paper)David Altshuler (1 shared paper)
- Journals
- Protein Science (1 paper)Journal of Medicinal Chemistry (1 paper)Journal of the American Society of Nephrology (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- United StatesUnited KingdomIsrael
In The Last Decade
Leslie Dakin
4 papers receiving 199 citations
Leslie Dakin's Hit Papers
Peers
Comparison fields: 5 of 46
- Nephrology 85
- Immunology 52
- Genetics 25
- Infectious Diseases 26
- Molecular Biology 85
Countries citing papers authored by Leslie Dakin
This map shows the geographic impact of Leslie Dakin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Dakin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Dakin more than expected).
Fields of papers citing papers by Leslie Dakin
This network shows the impact of papers produced by Leslie Dakin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Dakin. The network helps show where Leslie Dakin may publish in the future.
Co-authors
The 25 scholars most cited alongside Leslie Dakin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants Hit paper breakdown → | 2023 | 112 |
| 2 | 2017 | 57 | |
| 3 | 2016 | 28 | |
| 4 | 2021 | 3 |
About Leslie Dakin
Leslie Dakin is a scholar working on Nephrology, Molecular Biology, Genetics, Immunology and Infectious Diseases, having authored 4 papers that have together received 200 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper), Epigenetics and DNA Methylation (1 paper), Cancer-related gene regulation (1 paper), Immune Cell Function and Interaction (1 paper), Immune Response and Inflammation (1 paper), RNA modifications and cancer (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Nephrology (85 citations), Immunology (52 citations), Genetics (25 citations), Infectious Diseases (26 citations) and Molecular Biology (85 citations). Leslie Dakin has collaborated with scholars based in United States, United Kingdom and Israel. Frequent co-authors include A H Fortier, Brandon Zimmerman, George Manos, David J. Friedman, Kate Bramham, Bertrand Knebelmann, Martin R. Pollak, David Altshuler, Madalina Chirieac and Kirk N. Campbell. Their work appears in journals such as Protein Science, Journal of Medicinal Chemistry, Journal of the American Society of Nephrology and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.